Search





Search





Markets
/
Stocks
/
nasdaq-drio
/

DarioHealth Corp

DRIO

Add to Watchlist

8.300USD

+0.080+0.97%

Close 05/15, 16:00（ET）Quotes delayed by 15 min

60.69MMarket Cap

LossP/E TTM



DarioHealth Corp

8.300

+0.080+0.97%

Overview Financials Discussions Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of DarioHealth Corp

Currency: USD Updated: 2026-05-15

Key Insights

DarioHealth Corp's fundamentals are relatively very healthy, with industry-average ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 94 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 18.50.In the medium term, the stock price is expected to trend down.Despite a good stock market performance and strong technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

DarioHealth Corp's Score

Industry at a Glance

Industry Ranking

94 / 206

Overall Ranking

218 / 4482

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative-

DarioHealth Corp Highlights

StrengthsRisks

DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.

Growing

The company is in a growing phase, with the latest annual income totaling USD 22.36M.

Overvalued

The company’s latest PE is -0.54, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 782.90K shares, decreasing 22.05% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 0.00 shares of this stock.

Analyst Rating

Based on 4 analysts

Buy

Current Rating

18.500

Target Price

+120.63%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-15

The current financial score of DarioHealth Corp is 5.94, ranking 178 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 5.23M, representing a year-over-year decrease of 31.21%, while its net profit experienced a year-over-year decrease of 206.10%.

Score

Industry at a Glance

Previous score

5.94

Change



Financials

8.14

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.16

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

2.84

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

4.47

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.08

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

DarioHealth Corp's Company Valuation

Currency: USD Updated: 2026-05-15

The current valuation score of DarioHealth Corp is 7.51, ranking 77 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.54, which is -94.92% below the recent high of -0.03 and -330.05% above the recent low of -2.30.

Score

Industry at a Glance

Previous score

7.51

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 94/206

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-15

The current earnings forecast score of DarioHealth Corp is 8.00, ranking 66 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 18.50, with a high of 25.00 and a low of 11.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 4 analysts

Buy

Current Rating

18.500

Target Price

+120.63%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

116

Total

Median

Average

Company name

Ratings

Analysts

DarioHealth Corp

DRIO

Medtronic PLC

MDT

Stryker Corp

SYK

Zimmer Biomet Holdings Inc

ZBH

Abbott Laboratories

ABT

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-15

The current price momentum score of DarioHealth Corp is 9.13, ranking 18 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 9.04 and the support level at 7.33, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.19

Change

-0.06

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.269

Neutral

RSI(14)

55.447

Neutral

STOCH(KDJ)(9,3,3)

69.740

Neutral

ATR(14)

0.508

High Vlolatility

CCI(14)

94.734

Neutral

Williams %R

30.631

Buy

TRIX(12,20)

0.298

Sell

StochRSI(14)

22.722

Sell

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

8.289

Buy

MA10

8.080

Buy

MA20

7.716

Buy

MA50

7.923

Buy

MA100

9.530

Sell

MA200

10.708

Sell

Institutional Confidence

Currency: USD Updated: 2026-05-15

The current institutional shareholding score of DarioHealth Corp is 3.00, ranking 133 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 10.72%, representing a quarter-over-quarter increase of 39.76%. The largest institutional shareholder is The Vanguard, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 100.00% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Tasso Partners, LLC

612.56K

+594.94%

Kallman (Craig)

604.80K

Nantahala Capital Management, LLC

563.23K

-0.00%

Solid Financial LLC

106.98K

+20.64%

Raphael (Erez)

97.43K

-36.08%

Geode Capital Management, L.L.C.

49.57K

+167.87%

Stern (Adam K.)

35.18K

+0.55%

Avenue Capital Group

23.25K

+0.00%

Risk Assessment

Currency: USD Updated: 2026-05-15

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of DarioHealth Corp is 1.97, ranking 169 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.12. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. DarioHealth Corp’s latest ESG disclosure is at an average level in the Healthcare Equipment & Supplies industry, showing no material impact on overall risk.